Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P040042/S060

Therapy Dual-8 Ablation Catheter

Irvine Biomedical,Inc.(Ibi) · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONP040042/S060

What did the FDA decide?

The FDA record for P040042/S060 describes a 30-day notice supplement to PMA P040042, submitted by Irvine Biomedical, Inc. (IBI) for the Therapy Dual-8 Ablation Catheter, a percutaneous cardiac ablation catheter for treatment of atrial flutter (product code OAD). The stated purpose is to add an alternate epoxy in the manufacture of the temperature sensor. The record classifies this as a process change involving a manufacturer, sterilizer, packager or supplier, and lists the decision as OK30 dated 2026-09-03.

The identifier establishes that this is a supplement to the original P040042 approval, not a new approval of the whole system. The record states only the intended change: an alternate epoxy for the temperature sensor. It does not specify the epoxy's identity, the sensor design, which manufacturing step changes, or whether prior epoxy use continues. The statement does not show independent evidence of safety or clinical effectiveness, and no new indication or clinical use is recorded.

FDA approval order statement

to add an alternate epoxy in the manufacture of the temperature sensor
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 3, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P040042/S060
Regulatory pathway
PMA supplement
Product code
OAD
Decision code
OK30
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter.

Product code
OAD
FDA device class
3

For the original device and its historical approval scope, see PMA P040042. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P040042 · Original PMA

    THERAPY DUAL 8 CARDIAC ABLATION SYSTEM,THERAM 8MM THERMISTER ABLATION CATHETER SAFIRE TX ABLATION CATHETER

  2. P040042/S060 received

    Application receipt date recorded by FDA.

  3. P040042/S060 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P040042. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P040042

Product / regulatory recordCompanyPathwayDecision dateSource
Irvine Biomedical,Inc.(Ibi)PMA approvalNov 18, 2005FDA

Explore the linked device profile

Other records with product code OAD

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Irvine Biomedical,Inc.(Ibi)

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2375 Morse Ave., Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records